Research Paper Volume 14, Issue 6 pp 2880—2901

A systematic pan-cancer study demonstrates the oncogenic function of heterogeneous nuclear ribonucleoprotein C


Figure 1. HNRNPC expression in different tumor type. (A) The expression levels of the HNRNPC gene varies according to tumor type. in GTEx, Illumina, BioGPS, and SAGE. (B) TIMER2 was used to determine the amount of expression of the HNRNPC gene in various malignancies or particular cancer subtypes. (C) The TCGA project provided box plot data for pan-cancer, as well as normal tissues from the GTEx database as controls. (D) The expression level of HNRNPC total protein was determined in normal and primary tissues using the CPTAC dataset. (E) HPA-induced expression of the HNRNPC protein in tumor and tumor-adjacent normal tissues. * P < 0.05; ** P < 0.01; *** P < 0.001.